New Insights in Esophageal Cancer Diagnosis and Treatment
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 27 November 2026 | Viewed by 1171
Special Issue Editor
Special Issue Information
Dear Colleagues,
Esophageal cancer represents the 7th leading cancer worldwide, with the adenocarcinoma subtype rising in the Western Hemisphere. Unfortunately, the 5-year survival rate for this group of patients is approximately 20%. Targeted screening using various modalities and risk stratification of precursor lesions may help facilitate early diagnosis. Improvements in endoscopic treatments to preserve structural and functional integrity with early lesions and palliation in advanced disease are being undertaken. It is hoped that biomarker-driven systemic therapies will improve survival in advanced diseases. This Special Issue reflects the ongoing efforts to make esophageal adenocarcinoma a promptly diagnosable and potentially curable disease.
Dr. Virendra Joshi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- esophageal cancer
- diagnosis
- targeted screening
- endoscopic treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
